BFLYHealthcare · Medical DevicesThe 5 Wall Street analysts covering Butterfly Network, Inc. hold a median 12-month price target of $11 — +18.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 72 of 100 as at 13 Aug 2026 — in the upper half. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Butterfly Network, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Momentum (97): The shares have been drifting up relative to others.
Volatility (12): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on BFLY, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +18.8% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 2 Mar 2026 | Freedom Broker | Maintains | Buy | $5.00 → $5.50 |
| 27 Feb 2026 | TD Cowen | Maintains | Buy | $4.50 → $6.00 |
| 20 Jan 2026 | Lake Street | Maintains | Buy | — |
| 31 Dec 2025 | Freedom Broker | Initiates | Buy | — |
| 31 Dec 2025 | Freedom Capital Markets | Initiates | Buy | $5.00 |
| 1 July 2025 | Craig-Hallum | Initiates | Buy | — |
| 5 May 2025 | Lake Street | Maintains | Buy | — |
| 17 Mar 2025 | William Blair | Initiates | Outperform | — |
| 10 Sept 2024 | Lake Street | Initiates | Buy | — |
| 29 Mar 2023 | UBS | Initiates | Neutral | — |
| 29 Nov 2022 | Oppenheimer | Initiates | Outperform | — |
| 4 Oct 2022 | B. Riley Securities | Initiates | Buy | — |
| 17 Dec 2021 | UBS | Initiates | Neutral | — |
| 21 June 2021 | Cowen & Co. | Initiates | Outperform | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BFLY appears on the weeks it earns a place.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 97% of US stocks
Cheaper than 8% of US stocks
Cheaper than 8% of US stocks
Cheaper than 94% of US stocks
Higher than 83% of US stocks
Higher than 72% of US stocks
Higher than 84% of US stocks
Higher than 19% of US stocks
Higher than 8% of US stocks
Higher than 25% of US stocks
Higher than 26% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Butterfly Network, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Butterfly Network CEO Joseph Devivo sold 68,346 shares on August 10, 2026, for approximately $684,143, reducing his direct equity holdings by 0.89%.
Why it matters — Insider stock sales can signal a lack of confidence in the company's near-term outlook, so BFLY watchers may monitor for further selling activity.
Seeking Alpha reports that Butterfly Network's co-founder is fulfilling his ambition to change the world through the company's pioneering "ultrasound on a chip" technology, which sends scans to iPhones or similar devices and makes ultrasound accessible virtually anywhere.
Why it matters — For BFLY watchers, the piece underscores the company's core value proposition — its portable ultrasound technology — as a potentially transformative solution to a real-world healthcare problem of underutilized scanning due to logistical hurdles.
Butterfly Network congratulated Dr. Erica Schwartz on her confirmation as CDC director. Dr. Schwartz, who had served on Butterfly's Board of Directors since 2021, stepped down from the Board effective August 5, 2026, ahead of assuming her new role.
Why it matters — Having a former board member appointed to lead the CDC may strengthen Butterfly Network's visibility and credibility in public health circles and could create opportunities for its ultrasound technology in disease surveillance and prevention efforts.
Butterfly Network raised its 2026 outlook during its Q2 earnings call, citing surging Embedded revenues, expanding enterprise POCUS, and Home and Community Care moving toward Q4 revenues.
Why it matters — The raised 2026 outlook and growth across Embedded, enterprise POCUS, and Home and Community Care indicate strengthening momentum across BFLY's business segments.
Butterfly Network, Inc. held its Q2 2026 earnings call, with the transcript published by Seeking Alpha. The call covered the company's financial results and operational performance for the quarter.
Why it matters — Shareholders and prospective investors rely on earnings calls for management's commentary on financial health and strategic direction, making this a key event for BFLY watchers.
The 5 Wall Street analysts covering Butterfly Network, Inc. have a median 12-month price target of $11, with estimates ranging from $5.25 to $11. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 5 analysts covering Butterfly Network, Inc., 5 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Butterfly Network, Inc. 72 out of 100 across roughly 4,600 US stocks as at 13 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 13 Aug 2026, Butterfly Network, Inc. ranks 72 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (97 of 100).
No one can know that. What the data says: the median 12-month target from 5 analysts implies +18.8% from the last close, and Ticker Nerd's factor model ranks Butterfly Network, Inc. 72 out of 100 as at 13 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Butterfly Network, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BFLY are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $5.25 to $11 over the next 12 months.
Butterfly Network, Inc. returned +527.0% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Butterfly Network, Inc. is a healthcare technology company specializing in medical imaging and digital health solutions.
The most recent item we track (The Motley Fool, 14 Aug 2026): "Butterfly Network CEO Joseph Devivo Sells 68,346 Shares". Butterfly Network CEO Joseph Devivo sold 68,346 shares on August 10, 2026, for approximately $684,143, reducing his direct equity holdings by 0.89%.
Butterfly Network, Inc. is a healthcare technology company specializing in medical imaging and digital health solutions. It focuses on handheld, whole-body ultrasound powered by proprietary Ultrasound-on-Chip semiconductor technology, designed to make diagnostic imaging more portable and accessible in everyday clinical workflows. Its core product family includes Butterfly iQ+, iQ3, and specialized devices such as Butterfly iQ+ Bladder and Butterfly iQ+ Vet, all built around a single-probe, point-of-care ultrasound platform that connects to smartphones, tablets, and hospital computer systems. Beyond hardware, Butterfly Network provides cloud-based software, image storage and collaboration tools, teleguidance, workflow integration, and educational offerings including Butterfly Academy, Butterfly Certified courses, and the ScanLab training app. The company serves hospitals, health systems, physicians, mobile care providers, and veterinarians through direct sales, distributors, and e-commerce channels in the United States and select international markets. Founded in 2011 and headquartered in Burlington, Massachusetts, Butterfly Network operates as a single business segment encompassing devices, software, and professional services.
CEO Mr. Joseph M. DeVivo · 220 employees · United States · https://www.butterflynetwork.com